Contact us
General Contact
Business Development Contact
Pharmacovigilance
CSR
Insud Pharma
Español
Toggle navigation
Company
About us
CEO Message
Leadership Team
Business Growth story
Manifesto
Our locations
R&D
Biosimilars
Portfolio
Quality by design
Manufacturing
Single-Use Technology
Facilities
CDMO
Partnerships
B2B (Business to Business)
Media
News
What’s next? Meet us at…
Blog mAbxience
Join us
Company
About us
CEO Message
Leadership Team
Business Growth story
Manifesto
Our locations
R&D
Biosimilars
Portfolio
Quality by design
Manufacturing
Single-Use Technology
Facilities
CDMO
Partnerships
B2B (Business to Business)
Media
News
What’s next? Meet us at…
Blog mAbxience
Join us
Contact us
General Contact
Business Development Contact
Pharmacovigilance
CSR
Insud Pharma
Español
mAbxience |
Glossary
Find here all you need!
VIEW ALL
A - Z
Z - A
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
TRACEABILITY
S
SUBSTITUTION
SINGLE-USE TECHNOLOGY
SIMILARITY
R
Risk management system
Q
QUALITY
P
PHARMACOVIGILANCE
PHARMACOKINETIC TEST
PHARMACODYNAMIC TEST
PERFORMACE QUALIFICATION
Patent
O
OUTSOURCING ACTIVITIES
ORIGINATOR COMPANY
M
MONOCLONAL ANTIBODY (MAB)
MEDIA
MCB (MASTER CELL BANK)
Marketing authorisation
MANUFACTURING SCALE PRODUCTION
Mab
I
INTERCHANGEABILITY
INNOVATIVE REFERENCE DRUG
IMMUNOGENICITY
H
HLA
HIGH-AFFINITY ANTIBODY
HAPTEN
G
GMP
GLYCOSYLATION
GENETIC ENGINEERING
GENE TRANSFER
F
Fucosylation
FORMULATION
FINGERPRINT-LIKE
FEED
FDA
E
EXTRAPOLATION
EMA
C
COMPARABILITY
CLONE
CLINICAL STUDY TRIAL
CHMP
CHIMERIC TRANSGENE
cGMP
CELL LINE
CELL HARVESTING
CELL CULTURE
CELL BANK
CBER
B
BIOTECHNOLOGY
BIOSIMILARITY
BIOSIMILAR
BioSim
BIOPROCESSING
BIOPHARMACEUTICAL
BIOLOGICAL DRUGS
BIOEQUIVALENCE
BIOAVAILABILITY
BIOACTIVITY
BINDING
BATCH CULTURE
BACULOVIRUS
BACTERIOPHAGE
A
AVIDITY
ANTIGENITCITY
ANTIGEN DETERMINANT
ANTIGEN
ANTIBODY
Active ingredient (or active substance)
